Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overview: A New Era of Cancer Genome in Myeloid Malignancies.

Oncology - 1 Jan 2015

Kiyoi Hitoshi

Abstract excerpt

In the Myeloid session of the 30th Nagoya International Cancer Treatment Symposium, three speakers were invited. Prof. Clara Bloomfield emphasized the importance of genetic alterations for the prognostic stratification and treatment of acute myeloid leukemia (AML). Dr. Eytan Stein showed that there are promising anti-leukemia effects of IDH2 inhibitor, AG-221, and DOT1L inhibitor, EPZ-5676, based on early-phase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminopyridines
Share to Anemia, Aplastic
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clonal Evolution

Share to Hematopoiesis

Share to Histone-Lysine N-Methyltransferase

Share to Methyltransferases

Share to Triazines

Source

Identifiers

PMID: 26551625
DOI: 10.1159/000431054

Genes

IDH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overview: A New Era of Cancer Genome in Myeloid Malignancies.PMID 26551625Read ↗

What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.Semantic proximity Read ↗

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast CancersSemantic proximity Read ↗

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasmsSemantic proximity Read ↗

A new player in IDH1 mutated myeloid neoplasias.Semantic proximity Read ↗

Epigenetic therapy in hematological cancersSemantic proximity Read ↗

[Research Progress on Gene Mutation and CHIP in Pathogenesis of MDS --Review].Semantic proximity Read ↗

[Research on molecular markers for epigenetic changes in myeloid malignancies].Semantic proximity Read ↗

Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes.Semantic proximity Read ↗

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.Semantic proximity Read ↗

Clonal shifts in MDS - from SF3B1 to EZH2.Semantic proximity Read ↗

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.Semantic proximity Read ↗

[Genetic analysis and targeted therapy for acute myeloid leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.